Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastomaMaryam Fouladi, Murali Chintagumpala, David Ashley, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium studySridharan Gururangan, Christopher D Turner, Clinton F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Pediatric Blood & Cancer|April 3, 2016
Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk MelanomaFariba Navid, Cynthia E Herzog, John Sandoval, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Nature Genetics|March 28, 2015
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossHeng Xu, Giles W Robinson, Jie Huang, et al.
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastomaMaryam Fouladi, Murali Chintagumpala, David Ashley, et al.
Cancer Chemotherapy and Pharmacology|January 12, 2007
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt, Jeffrey W Clark, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium studySridharan Gururangan, Christopher D Turner, Clinton F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Pediatric Blood & Cancer|April 3, 2016
Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk MelanomaFariba Navid, Cynthia E Herzog, John Sandoval, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Nature Genetics|March 28, 2015
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossHeng Xu, Giles W Robinson, Jie Huang, et al.
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Pageof 22